Wenxia Changfu Formula inhibits NSCLC metastasis by halting TAMs-induced epithelial-mesenchymal transition via antagonistically modulating CCL18
摘要： Our previous research demonstrated that the Wenxia Changfu Formula (WCF),as a neoadjuvant therapy,inhibits M2 macrophage infiltration in the tumor microenvironment and prevents lung cancer m... ...
（共10页）
开通会员，享受整站包年服务
说明： 本文档由创作者上传发布，版权归属创作者。若内容存在侵权，请点击申诉举报
APP